Company profile:

Bristol-Myers Squibb (China) Co., Ltd

Country: China

Legal Representative: Chen Siyuan

Business status: Active

Industry: Investment and Asset Management

Company type: Limited liability company (wholly owned by foreign legal person)

Founding date: 1998-11-09

Approval date: 2023-06-13

Chinese company name: 百时*施贵宝（中国）投资有限公司

Telephone: 021-232181** ,021232181**

Email: **.yu@bms.com ,

Bristol-Myers Squibb (China) Co., Ltd

Employees	500-1,000 Detail	( 72.48% of companies have fewer than 5 employees. )
Registered capital	105,000,000 Dollar Detail	( 6.3% of companies have registered capital less than 500,000. )
Paid up capital	Over 100 Million RMB Detail	( 42.7% of companies have paid up capital less than 500,000. )
	The preceding data analysis is derived from a sample of 2 million Chinese companies with import and export licenses, as of October 9, 2023.

Company's Shareholders

Bristol-Myers Squibb Company

They invested companies

Company's business scope

1. Medicines encouraged and permitted by the state、Nutrients、 Investing in personal care products and medical equipment； 2. Receive written authorization from the enterprise in which it invests（ unanimously approved by its board of directors），Provide the following services to its invested enterprises：1. Assisting or acting as an agent for the invested enterprise to purchase the machinery and equipment for the enterprise's own use from home and abroad、Office equipment and raw materials required for production、components、Parts；， 2. Assist or act as an agent for the companies in which it invests to sell products produced by the companies in which it invests at home and abroad and provide after-sales services； 3. With the consent and supervision of the foreign exchange management department，Balance foreign exchange among the companies it invests in； 4. Provide product production for the companies it invests in、Technical support during sales and market development、employee training、Internal personnel management and other services； 5. Assist the companies it invests in seeking loans and providing guarantees； 3. Establishing scientific research and development centers or departments in China，Engaged in the research and development of new products and high-tech（ Including but not limited to organizing clinical trials of new drugs、 Collect and store clinical trial data、 Apply for a new drug certificate、 New drug patents and trademarks, etc.），Transfer of its research and development results，And provide corresponding technical services； 4. Engage in marketing and promotion activities of Bristol-Myers Squibb Group’s products in China； 5. Provide consulting services to its investors， Provide affiliated companies with market information relevant to their investments、 Investment policy consulting services； 6. Undertake the service outsourcing business of its parent company and affiliated companies； 7. Engage in parent company、 Wholesale of similar products produced by affiliated companies and subsidiaries、commission agency（except auction）、Import and export and related supporting services（medicine、Nutrients、 Wholesale of Class II and III medical devices、 Except for commission agents）。【Items subject to approval by law，Business activities can only be carried out after approval by relevant departments】